{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:54:47Z","timestamp":1792079687036,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Qingdao People\u2019s Livelihood Science and Technology Plan","award":["13-1-3-34-nsh"],"award-info":[{"award-number":["13-1-3-34-nsh"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.toxicon.2016.11.009","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T23:32:24Z","timestamp":1478734344000},"page":"70-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Intra-articular injection of Botulinum toxin A reduces neurogenic inflammation in CFA-induced arthritic rat model"],"prefix":"10.1016","volume":"126","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaile","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoman","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2016.11.009_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.toxicon.2016.11.009_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pbb.2009.08.012","article-title":"Central origin of the antinociceptive action of botulinum toxin type A","volume":"94","author":"Bach-Rojecky","year":"2009","journal-title":"Pharmacol. Biochem Behav."},{"key":"10.1016\/j.toxicon.2016.11.009_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.toxicon.2016.11.009_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3959(92)90133-V","article-title":"A\u00a0limited arthritic model for chronic pain studies in the rat","volume":"48","author":"Butler","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2016.11.009_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.toxicon.2016.11.009_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2016.11.009_bib7","first-page":"441","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.toxicon.2016.11.009_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2006.01648.x","article-title":"The structure and mode of action of different botulinum toxins","volume":"13","author":"Dolly","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2016.11.009_bib9","first-page":"11","article-title":"Interleukin-1\u03b2 and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis","volume":"16","author":"Ferraccioli","year":"2010","journal-title":"Cell Motil. Cytoskelet."},{"key":"10.1016\/j.toxicon.2016.11.009_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pain.2008.10.005","article-title":"Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin","volume":"141","author":"Gazerani","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2016.11.009_bib11","first-page":"21","article-title":"Assembly and function of the botulinum neurotoxin progenitor complex","volume":"364","author":"Gu","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.toxicon.2016.11.009_bib12","doi-asserted-by":"crossref","first-page":"e1003690","DOI":"10.1371\/journal.ppat.1003690","article-title":"Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity","volume":"9","author":"Lee","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.toxicon.2016.11.009_bib13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.mehy.2007.03.019","article-title":"Botulinum toxin, Quo Vadis?","volume":"69","author":"Lim","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.toxicon.2016.11.009_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.toxicon.2009.03.028","article-title":"Intra-articular Botulinum Toxin Type A: a new approach to treat arthritis joint pain","volume":"54","author":"Mahowald","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2016.11.009_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0049-0172(10)80020-4","article-title":"The role of substance P in rheumatic disease","volume":"23","author":"Mapp","year":"1994","journal-title":"Semin. Arthritis & Rheumatol."},{"key":"10.1016\/j.toxicon.2016.11.009_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","article-title":"Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A","volume":"186","author":"Matak","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxicon.2016.11.009_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuint.2012.05.001","article-title":"Botulinum toxin's axonal transport from periphery to the spinal cord","volume":"61","author":"Matak","year":"2012","journal-title":"Neurochem Int."},{"key":"10.1016\/j.toxicon.2016.11.009_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tim.2004.08.002","article-title":"Presynaptic receptor arrays for clostridial neurotoxins","volume":"12","author":"Montecucco","year":"2004","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.toxicon.2016.11.009_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1744-8069-1-3","article-title":"Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins","volume":"1","author":"Moriyama","year":"2005","journal-title":"Mol. Pain"},{"key":"10.1016\/j.toxicon.2016.11.009_bib20","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1046\/j.1526-4610.43.7s.4.x","article-title":"Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins","volume":"43","author":"O","year":"2003","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2016.11.009_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0041-0101(00)00163-X","article-title":"Tetanus and botulinum neurotoxins: turning bad guys into good by research","volume":"39","author":"Rossetto","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2016.11.009_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(93)90183-P","article-title":"Afferent and spinal mechanisms of joint pain","volume":"55","author":"Schaible","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2016.11.009_bib23","doi-asserted-by":"crossref","first-page":"23784","DOI":"10.1016\/S0021-9258(20)80452-9","article-title":"Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E","volume":"268","author":"Schiavo","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2016.11.009_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nbd.2012.07.010","article-title":"Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A","volume":"48","author":"Shimizu","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.toxicon.2016.11.009_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)06852-8","article-title":"The origin, structure, and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxicon.2016.11.009_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.trsl.2009.02.004","article-title":"Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial","volume":"153","author":"Singh","year":"2009","journal-title":"Transl. Res."},{"key":"10.1016\/j.toxicon.2016.11.009_bib27","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/1529-0131(199912)42:12<2532::AID-ANR5>3.0.CO;2-2","article-title":"Suppressed severity of collagen-induced arthritis by in\u00a0vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy","volume":"42","author":"Tomita","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.toxicon.2016.11.009_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1744-8069-3-22","article-title":"Prostaglandin E2 potentiation of P2X3 receptor mediated currents in dorsal root ganglion neurons","volume":"3","author":"Wang","year":"2007","journal-title":"Mol. Pain"},{"key":"10.1016\/j.toxicon.2016.11.009_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12640-013-9447-7","article-title":"Anti-inflammatory effects of botulinum toxin type a in a complete Freund's adjuvant-induced arthritic knee joint of hind leg on rat model","volume":"26","author":"Yoo","year":"2014","journal-title":"Neurotox. Res."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010116303403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010116303403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T08:21:17Z","timestamp":1749716477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010116303403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":29,"alternative-id":["S0041010116303403"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2016.11.009","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-articular injection of Botulinum toxin A reduces neurogenic inflammation in CFA-induced arthritic rat model","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2016.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}